About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Npj Vaccines
›
Top Articles
Npj Vaccines
Pharmacology
,
Biology
,
Immunology
9.5
(top 1%)
Impact Factor
10.4
(top 1%)
extended IF
39
(top 10%)
H-Index
1.1K
authors
461
papers
7.2K
citations
1K
citing journals
7.6K
citing authors
Most Cited Articles of Npj Vaccines
Title
Year
Citations
Turning the corner on therapeutic cancer vaccines
2019
303
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
2021
229
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
2020
155
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
2020
153
The promise of mRNA vaccines: a biotech and industrial perspective
2020
151
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
2018
150
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
2017
111
The how's and what's of vaccine reactogenicity
2019
111
Antibody therapies for the prevention and treatment of viral infections
2017
106
protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
2016
101
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
2017
97
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
2021
87
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
2020
86
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
2017
85
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
2018
77
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
2017
66
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
2018
66
Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females
2019
64
derived virus-like particles in vaccine development
2017
60
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
2018
60
Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases
2021
60
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
2021
60
COVID-19 vaccines: breaking record times to first-in-human trials
2020
58
Malaria vaccines since 2000: progress, priorities, products
2020
55
Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness
2018
55
previous
2014
2015
2016
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.